Cargando…
The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well‐controlled plasma LDL cholesterol
AIM: To dissect the effects of the sodium‐glucose linked transporter 2 inhibitor dapagliflozin on lipid metabolism and assess whether these effects could potentially offset cardiovascular benefit with this drug‐class. MATERIALS AND METHODS: We assessed the effect of dapagliflozin on lipid metabolism...
Autores principales: | Bouter, Kristien E. C., van Bommel, Erik J. M., Jansen, Hans, van Harskamp, Dewi, Schierbeek, Henk, Ackermans, Mariëtte T., Serlie, Mireille J., Schimmel, Alinda W. M., Nieuwdorp, Max, Dallinga‐Thie, Geesje M., van Raalte, Daniël H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318266/ https://www.ncbi.nlm.nih.gov/pubmed/32026592 http://dx.doi.org/10.1111/dom.13990 |
Ejemplares similares
-
Bariatric surgery improves postprandial VLDL kinetics and restores insulin-mediated regulation of hepatic VLDL production
por: Yildirim, Vehpi, et al.
Publicado: (2023) -
ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia—Brief Report
por: Reeskamp, Laurens F., et al.
Publicado: (2021) -
Causality of small and large intestinal microbiota in weight regulation and insulin resistance
por: Scheithauer, Torsten P.M., et al.
Publicado: (2016) -
Decreased GPIHBP1 protein levels in visceral adipose tissue partly underlie the hypertriglyceridemic phenotype in insulin resistance
por: Surendran, R. Preethi, et al.
Publicado: (2018) -
In Vivo Inflammation Does Not Impair ABCA1-Mediated Cholesterol Efflux Capacity of HDL
por: Franssen, Remco, et al.
Publicado: (2012)